Beauty Health Debt to Equity Ratio 2020-2024 | SKIN
Beauty Health Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2024-12-31 | $0.63B | $0.05B | 12.24 |
2024-09-30 | $0.64B | $0.06B | 10.71 |
2024-06-30 | $0.64B | $0.07B | 9.29 |
2024-03-31 | $0.78B | $0.06B | 12.35 |
2023-12-31 | $0.87B | $0.06B | 14.64 |
2023-09-30 | $0.88B | $0.09B | 9.82 |
2023-06-30 | $0.85B | $0.16B | 5.23 |
2023-03-31 | $0.85B | $0.15B | 5.74 |
2022-12-31 | $0.84B | $0.17B | 5.01 |
2022-09-30 | $0.85B | $0.26B | 3.28 |
2022-06-30 | $0.86B | $0.35B | 2.45 |
2022-03-31 | $0.86B | $0.34B | 2.51 |
2021-12-31 | $0.92B | $0.30B | 3.03 |
2021-09-30 | $1.14B | $-0.14B | -8.03 |
2021-06-30 | $0.33B | $0.02B | 20.31 |
2021-03-31 | $0.53B | $-0.07B | -8.14 |
2020-12-31 | $0.00B | 0.00 | |
2020-09-30 | $0.00B | $0.00B | 17.62 |
2020-06-30 | $0.00B | $0.00B | 0.00 |
2019-12-31 | $0.00B | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.106B | $0.334B |
The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $133.529B | 24.94 |
Elevance Health (ELV) | United States | $96.108B | 12.88 |
CVS Health (CVS) | United States | $84.839B | 12.41 |
Cencora (COR) | United States | $55.604B | 20.18 |
DiDi Global (DIDIY) | China | $20.317B | 29.86 |
Natera (NTRA) | United States | $20.018B | 0.00 |
BioMerieux (BMXMF) | France | $15.594B | 0.00 |
Solventum (SOLV) | United States | $11.463B | 10.69 |
ICON (ICLR) | Ireland | $11.251B | 10.22 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
Revvity (RVTY) | United States | $11.032B | 18.74 |
CochLear (CHEOY) | Australia | $10.876B | 0.00 |
Avantor (AVTR) | United States | $10.289B | 15.10 |
Doximity (DOCS) | United States | $9.934B | 51.66 |
Viatris (VTRS) | United States | $9.024B | 2.85 |
Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
HealthEquity (HQY) | United States | $7.311B | 35.97 |
Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
Sotera Health (SHC) | United States | $2.975B | 17.18 |
BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
Organon (OGN) | United States | $2.868B | 2.92 |
Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
Concentras Parent (CON) | United States | $2.613B | 13.59 |
Progyny (PGNY) | United States | $1.837B | 40.45 |
Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
Premier (PINC) | United States | $1.765B | 11.30 |
GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
Agilon Health (AGL) | United States | $1.649B | 0.00 |
PACS (PACS) | United States | $1.411B | 0.00 |
Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
CareDx (CDNA) | United States | $0.977B | 16.62 |
Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
Nutex Health (NUTX) | United States | $0.824B | 16.14 |
AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
Embecta (EMBC) | United States | $0.659B | 4.52 |
Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
SBC Medicals (SBC) | United States | $0.417B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
Enhabit (EHAB) | United States | $0.388B | 36.57 |
InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
LifeMD (LFMD) | United States | $0.242B | 0.00 |
DocGo (DCGO) | United States | $0.216B | 8.83 |
Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
Oncology Institute (TOI) | United States | $0.163B | 0.00 |
Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
So-Young (SY) | China | $0.084B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.081B | 0.00 |
Biodesix (BDSX) | United States | $0.080B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
ModivCare (MODV) | United States | $0.014B | 4.93 |
Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
KindlyMD (KDLY) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
Aclarion (ACON) | United States | $0.005B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |